Literature DB >> 28393395

Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province, China and related risk factors.

Yuan-Yuan Qin1, Peng Wang2, Jin-Qiu Qin1, Ai-Qiu Wei1, Ping Huang2, Zhan-Feng Lai1, Fa-Quan Lin1.   

Abstract

BACKGROUND: Studies on homocysteine (Hcy) have mainly focused on the correlation between the homocysteine concentration and disease development. Few epidemiological investigations have been performed. This study was conducted to investigate the prevalence of hyperhomocysteinemia (HHcy) during routine physical examination in Guangxi Province, China and the correlation of serum Hcy with gender, age, serum uric acid (UA), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and blood glucose (GLU) to provide evidence for preventing and treating HHcy.
METHODS: Data of 8043 patients who underwent physical examinations at the First Affiliated Hospital of Guangxi Medical University, China from 2015 to 2016 were collected. These data included gender, age, and the serum Hcy, UA, GLU, TC, TG, HDL-C, and LDL-C concentrations.
RESULTS: The overall prevalence of HHcy was 50.8% (52.3% in males, 48.1% in females). Age, UA, TC, TG, and LDL-C were significantly higher and HDL-C was significantly lower in patients with than without HHcy, regardless of gender (all P<.05). The Hcy level was positively correlated with UA, TC, TG, and LDL-C but negatively correlated with HDL-C. Gender, age, UA, TC, and TG were independent risk factors for HHcy.
CONCLUSION: The prevalence of HHcy was very high during routine physical examination in Guangxi Province, China. HHcy was related to gender, age, high concentrations of UA, TC, TG, and LDL-C; and low concentrations of HDL-C. Strengthening early intervention of HHcy can reduce the risk of cardiovascular disease.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  blood glucose; blood lipid; homocysteine; hyperhomocysteinemia; uric acid

Mesh:

Substances:

Year:  2017        PMID: 28393395      PMCID: PMC6817046          DOI: 10.1002/jcla.22178

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

1.  Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing.

Authors:  Zhi-Yan Li; Guo-Bing Xu; Tie-An Xia
Journal:  Atherosclerosis       Date:  2005-05-31       Impact factor: 5.162

2.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

3.  Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue.

Authors:  Yang Li; Heng Zhang; Changtao Jiang; Mingjiang Xu; Yanli Pang; Juan Feng; Xinxin Xiang; Wei Kong; Guoheng Xu; Yin Li; Xian Wang
Journal:  J Biol Chem       Date:  2013-02-17       Impact factor: 5.157

4.  Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.

Authors:  Bamini Gopinath; Victoria M Flood; Elena Rochtchina; Aravinda Thiagalingam; Paul Mitchell
Journal:  Eur J Prev Cardiol       Date:  2011-09-29       Impact factor: 7.804

5.  B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients.

Authors:  F O'Leary; V M Flood; P Petocz; M Allman-Farinelli; S Samman
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

6.  High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status.

Authors:  Ling Hao; Jing Ma; Jianghui Zhu; Meir J Stampfer; Yihua Tian; Walter C Willett; Zhu Li
Journal:  J Nutr       Date:  2007-02       Impact factor: 4.798

7.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.

Authors:  O Nygård; S E Vollset; H Refsum; I Stensvold; A Tverdal; J E Nordrehaug; M Ueland; G Kvåle
Journal:  JAMA       Date:  1995-11-15       Impact factor: 56.272

8.  Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration.

Authors:  M R Malinow; J Levenson; P Giral; F J Nieto; M Razavian; P Segond; A Simon
Journal:  Atherosclerosis       Date:  1995-04-24       Impact factor: 5.162

9.  Hyperhomocysteinemia as a component of syndrome X.

Authors:  Mor Oron-Herman; Talma Rosenthal; Ben-Ami Sela
Journal:  Metabolism       Date:  2003-11       Impact factor: 8.694

10.  Evaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes.

Authors:  Nahid Ashjazadeh; Morteza Fathi; Abdohamid Shariat
Journal:  Iran J Med Sci       Date:  2013-09
View more
  3 in total

1.  Estradiol and Hyperhomocysteinemia Are Linked Predominantly Through Part Renal Function Indicators.

Authors:  Xiao Na Niu; He Wen; Nan Sun; Yi Yang; Shi Hong Du; Rong Xie; Yan Nan Zhang; Yan Li; Xiu Qin Hong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-18       Impact factor: 6.055

2.  Plasma Homocysteine Level Is Independently Associated With Conventional Atherogenic Lipid Profile and Remnant Cholesterol in Adults.

Authors:  Liyuan Zhou; Jia Liu; Yu An; Ying Wang; Guang Wang
Journal:  Front Cardiovasc Med       Date:  2022-06-13

3.  Methylenetetrahydrofolate Reductase Gene C677T Polymorphism-Dietary Pattern Interaction on Hyperhomocysteinemia in a Chinese Population: A Cross-Sectional Study.

Authors:  Song Leng; Ai Zhao; Jian Zhang; Wei Wu; Qian Wang; Shan Wu; Li Chen; Qiang Zeng
Journal:  Front Cardiovasc Med       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.